Monographie - Fenoldopam mesylate

Ultimo aggiornamento :
19/11/2024

Fenoldopam mesylate

Struttura chimica

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Corlopam

Italia, Stati Uniti d’America

Bibliografia : Fenoldopam mesylate

	tipo	pubblicazione
1618	Rivista	Trissel LA, Zhang Y, Baker MB. Stability of fenoldopam in two infusion solutions. Am J Health-Syst Pharm 2002 ; 59: 846-848.
1712	Rivista	Trissel LA, Saenz CA. Compatibility screening of Precedex during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 230-233.
1803	Rivista	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
1963	Rivista	Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS. Compatibility of argatroban with selected cardiovascular agents. Am J Health-Syst Pharm 2004 ; 61: 2415-2418.
2108	Rivista	Trusley C, Kupiec TC, Trissel LA. Compatibility of micafungin injection with other drugs during simulated Y-site co-administration. Int J Pharm Compound 2006 ; 10: 230-232.

Mentions Légales